Prostate cancer: estimating the benefits of PSA screening

Nat Rev Urol. 2009 Jun;6(6):301-3. doi: 10.1038/nrurol.2009.95.

Abstract

Two groundbreaking trials have this year reported conflicting results as to the benefit of screening for prostate cancer. Careful interpretation in the light of contemporary data is needed to reveal the value of this intervention.

Publication types

  • News

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / blood*
  • Humans
  • Male
  • Mass Screening / methods
  • Mass Screening / standards*
  • Mass Screening / statistics & numerical data
  • Middle Aged
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / blood*
  • Prostatic Neoplasms / diagnosis
  • Randomized Controlled Trials as Topic / methods
  • Randomized Controlled Trials as Topic / standards
  • Randomized Controlled Trials as Topic / statistics & numerical data

Substances

  • Biomarkers, Tumor
  • Prostate-Specific Antigen